Locally Advanced Gastric Cancer Clinical Trials

24 clinical trials for Locally Advanced Gastric Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer — RECRUITING · NA
• Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC) — RECRUITING
• Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy — RECRUITING · NA
• The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer — RECRUITING
• Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer — RECRUITING · PHASE3
• HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer — NOT_YET_RECRUITING · PHASE2
• Ipilimumab (N01) Plus Sintilimab and Modified XELOX as Conversion Therapy in Unresectable Locally Advanced Gastric Cancer — NOT_YET_RECRUITING · PHASE2
• Machine Learning Model Guided by TLS Predicts Survival and Immune Features in Gastric Cancer — COMPLETED
• Trajectory of Body Composition Identifies LAGC with Cachexia Following NACT — COMPLETED
• Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer — NOT_YET_RECRUITING · PHASE2
• Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy — OTHER
• The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer — OTHER
• Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes — NOT_YET_RECRUITING · PHASE3
• Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer — OTHER · PHASE2
• Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma — OTHER · PHASE2
• Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes — NOT_YET_RECRUITING · PHASE2
• A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer. — OTHER · PHASE2
• Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer — OTHER · PHASE2
• Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy — OTHER · PHASE2
• Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer — OTHER · PHASE2
• Metronomic Chemotherapy in Advanced Gastric Cancer — OTHER · PHASE2
• A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer. — COMPLETED
• Comparison of Short Term Outcomes Between Totally Laparoscopic and Laparoscopy-Assisted Distal Gastrectomy With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer — OTHER · NA
• A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery — OTHER · PHASE3

Refine this search